This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Fudan University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: Innovations of Jingfang Mu in Antiviral Research
Introduction
Jingfang Mu is a notable inventor based in Wuhan, China. He has made significant contributions to the field of antiviral research, particularly in developing polypeptides that target enteroviruses. His work is crucial in the ongoing battle against viral infections that pose a threat to public health.
Latest Patents
Jingfang Mu holds a patent for a broad-spectrum polypeptide against enterovirus and its applications. This invention provides a series of polypeptides with antiviral activity. The present invention offers a new strategy for preventing and controlling enteroviruses such as EV71, CVA16, CVA6, CVB3, and CVB5. It also provides a theoretical basis for accelerating the research and development of small molecule drugs targeting these viruses. He has 1 patent to his name.
Career Highlights
Throughout his career, Jingfang Mu has worked with prestigious institutions, including the Chinese Academy of Sciences and Fudan University. His research has focused on innovative solutions to combat viral infections, showcasing his dedication to advancing medical science.
Collaborations
Jingfang Mu has collaborated with notable colleagues, including Xi Zhou and Lu Lu. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Jingfang Mu's innovative work in antiviral research highlights the importance of developing effective treatments for enteroviruses. His contributions are paving the way for future advancements in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile